DuPont de Nemours (NYSE:DD) Price Target Raised to $178.00

DuPont de Nemours (NYSE:DDFree Report) had its price objective upped by UBS Group from $175.00 to $178.00 in a research note issued to investors on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the basic materials company’s stock.

Other equities analysts have also recently issued research reports about the company. BMO Capital Markets upped their price target on DuPont de Nemours from $75.30 to $180.00 and gave the company an “outperform” rating in a report on Tuesday, May 5th. The Goldman Sachs Group boosted their price objective on DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Bank of America cut their target price on DuPont de Nemours from $150.00 to $141.00 and set a “neutral” rating for the company in a research note on Tuesday, April 21st. Morgan Stanley lifted their price target on shares of DuPont de Nemours from $132.00 to $156.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 28th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of DuPont de Nemours in a report on Monday. Twelve investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $165.13.

View Our Latest Report on DD

DuPont de Nemours Stock Performance

Shares of DuPont de Nemours stock opened at $142.50 on Wednesday. The stock has a market cap of $19.24 billion, a PE ratio of 316.70, a price-to-earnings-growth ratio of 1.32 and a beta of 1.06. The business has a fifty day simple moving average of $139.70 and a 200-day simple moving average of $140.55. The company has a quick ratio of 2.11, a current ratio of 2.43 and a debt-to-equity ratio of 0.23. DuPont de Nemours has a 12 month low of $87.26 and a 12 month high of $157.98.

DuPont de Nemours (NYSE:DDGet Free Report) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.76 by $0.12. The firm had revenue of $1.82 billion for the quarter, compared to the consensus estimate of $1.81 billion. DuPont de Nemours had a net margin of 0.67% and a return on equity of 6.92%. The business’s quarterly revenue was up 4.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. On average, sell-side analysts anticipate that DuPont de Nemours will post 7.25 EPS for the current fiscal year.

DuPont de Nemours Cuts Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Monday, August 31st will be paid a $0.60 dividend. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.7%. DuPont de Nemours’s dividend payout ratio is 533.33%.

Institutional Investors Weigh In On DuPont de Nemours

Several large investors have recently made changes to their positions in the stock. Palisade Asset Management LLC bought a new position in DuPont de Nemours in the third quarter valued at $26,000. Imprint Wealth LLC bought a new position in shares of DuPont de Nemours in the 3rd quarter valued at about $27,000. Basepoint Wealth LLC acquired a new stake in shares of DuPont de Nemours in the fourth quarter valued at about $28,000. Nalls Sherbakoff Group LLC acquired a new position in DuPont de Nemours during the fourth quarter valued at approximately $29,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of DuPont de Nemours during the 3rd quarter worth approximately $30,000. Institutional investors own 73.96% of the company’s stock.

About DuPont de Nemours

(Get Free Report)

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.

Read More

Analyst Recommendations for DuPont de Nemours (NYSE:DD)

Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.